TY - JOUR
T1 - Risk factors for isolation of low-level mupirocin-resistant versus -susceptible methicillin-resistant Staphylococcus aureus from patients in intensive care units
AU - Park, Dae Won
AU - Kim, Min Ja
AU - Yang, Jin Ah
AU - Jeong, Hye Won
AU - Sohn, Jang Wook
AU - Chun, Byung Chul
PY - 2007/4
Y1 - 2007/4
N2 - Objectives: The aim of this study was to determine the risk factors for the recovery of low-level mupirocin-resistant (mupr) or -susceptible (mups) MRSA from patients in intensive care units (ICUs). Methods: A case-case-control study was conducted from November 2003 to April 2004. Two case groups consisted of patients with low-level mupr MRSA and mups MRSA. A control group was frequency matched. Results: Mupr MRSA and mups MRSA were isolated from 20 to 51 patients, respectively, during a six-month period. Risk factors identified for mupr MRSA were as follows: exposure to piperacillin-tazobactam (odds ratio [OR] 13.8; 95% confidence intervals [CI], 1.8-105.0), third-generation cephalosporins (OR, 5.0; 95% CI, 1.6-15.5) and quinolones (OR, 3.4; 95% CI, 1.1-10.7). Risk factors identified for mups MRSA were as follows: length of ICU stay (OR, 1.1; 95% CI, 1.0-1.1), surgery (OR, 3.7; 95% CI, 1.5-9.0), exposure to third-generation cephalosporins (OR, 8.4; 95% CI, 3.3-21.7) and quinolones (OR, 7.7; 95% CI, 2.8-21.3). Conclusions: Our results suggest that nosocomial isolation of low-level mupr MRSA may be affected by piperacillin-tazobactam.
AB - Objectives: The aim of this study was to determine the risk factors for the recovery of low-level mupirocin-resistant (mupr) or -susceptible (mups) MRSA from patients in intensive care units (ICUs). Methods: A case-case-control study was conducted from November 2003 to April 2004. Two case groups consisted of patients with low-level mupr MRSA and mups MRSA. A control group was frequency matched. Results: Mupr MRSA and mups MRSA were isolated from 20 to 51 patients, respectively, during a six-month period. Risk factors identified for mupr MRSA were as follows: exposure to piperacillin-tazobactam (odds ratio [OR] 13.8; 95% confidence intervals [CI], 1.8-105.0), third-generation cephalosporins (OR, 5.0; 95% CI, 1.6-15.5) and quinolones (OR, 3.4; 95% CI, 1.1-10.7). Risk factors identified for mups MRSA were as follows: length of ICU stay (OR, 1.1; 95% CI, 1.0-1.1), surgery (OR, 3.7; 95% CI, 1.5-9.0), exposure to third-generation cephalosporins (OR, 8.4; 95% CI, 3.3-21.7) and quinolones (OR, 7.7; 95% CI, 2.8-21.3). Conclusions: Our results suggest that nosocomial isolation of low-level mupr MRSA may be affected by piperacillin-tazobactam.
KW - MRSA
KW - Mupirocin
KW - Piperacillin-tazobactam
KW - Resistance
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=33947148215&partnerID=8YFLogxK
U2 - 10.1016/j.jinf.2006.06.008
DO - 10.1016/j.jinf.2006.06.008
M3 - Article
C2 - 16860870
AN - SCOPUS:33947148215
SN - 0163-4453
VL - 54
SP - 337
EP - 342
JO - Journal of Infection
JF - Journal of Infection
IS - 4
ER -